YS Biopharma Announces US$40 Million Private Placement Financing
GAITHERSBURG, Md., Feb. 9, 2024 -- (Healthcare Sales & Marketing Network) -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical company d... Biopharmaceuticals, Venture Capital YS Biopharma, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 9, 2024 Category: Pharmaceuticals Source Type: news

PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
LAGUNA HILLS, Calif., Feb. 8, 2024 -- (Healthcare Sales & Marketing Network) -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced the appointment of Chris Emery to the... Diagnostics, Oncology, Personnel PreludeDx, DecisionTree (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2024 Category: Pharmaceuticals Source Type: news

Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System(TM) in Patients
IRVINE, Calif., Feb. 7, 2024 -- (Healthcare Sales & Marketing Network) -- Innova Vascular, Inc. today announced successful early commercial use of the company's Laguna Thrombectomy System™. Physicians at UCLA Medical Center in Los Angeles, California, and... Devices, Interventional Innova Vascular, Laguna Thrombectomy System, Malibu Aspiration Catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2024 Category: Pharmaceuticals Source Type: news

Zynex Receives FDA Clearance for its Next Generation NMES Device
ENGLEWOOD, Colo., Feb. 6, 2024 -- (Healthcare Sales & Marketing Network) -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, ... Devices, FDA Zynex, M-Wave, Neuromuscular Electrical Stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2024 Category: Pharmaceuticals Source Type: news

FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
ROSWELL, Ga., Feb. 6, 2024 -- (Healthcare Sales & Marketing Network) -- StimLabs® announces FDA 510(k) clearance of Corplex P, the pioneering human umbilical cord-derived medical device. This first-of-its-kind clearance marks a significant milestone f... Devices, Wound Care, FDA StimLabs, Corplex P, extracellular matrix (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2024 Category: Pharmaceuticals Source Type: news

Spyre Therapeutics Appoints Accomplished Biopharma and IBD Leader Mark C. McKenna, Former Chairman, President, and CEO of Prometheus Biosciences, to its Board of Directors
WALTHAM, Mass., Feb. 5, 2024 -- (Healthcare Sales & Marketing Network) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, ratio... Biopharmaceuticals, Personnel Spyre Therapeutics, Inflammatory Bowel Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2024 Category: Pharmaceuticals Source Type: news

Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
CARLSBAD, Calif., Feb. 2, 2024 -- (Healthcare Sales & Marketing Network) -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibrobla... Biopharmaceuticals, Venture Capital Tyra Biosciences, precision medicine, Fibroblast Growth Factor Receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 2, 2024 Category: Pharmaceuticals Source Type: news

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow(R) (EGF(R)) Mapping for use in Atrial Fibrillation Ablation
EGF Mapping system aims to improve patient outcomes by enabling precise and personalized ablation strategies MENLO PARK, Calif., Feb. 1, 2024 -- (Healthcare Sales & Marketing Network) -- Cortex announced today the initiation of its RESOLVE-AF trial (NC... Devices, Cardiology Cortex , RESOLVE-AF, Ablamap System, Ablacath Mapping Catheter, AFib (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2024 Category: Pharmaceuticals Source Type: news

Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
B•R•A•H•M•S™ sFlt-1/PlGF KRYPTOR™ Test System is available through physicians and is the first FDA-cleared biomarker test to aid in the risk assessment of progression to preeclampsia with severe features, a leading cause of maternal and fetal mortality in ... Diagnostics, Product Launch Labcorp, B•R•A•H•M•S, sFlt-1/PlGF KRYPTOR, preeclampsia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2024 Category: Pharmaceuticals Source Type: news

BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions FRANKLIN LAKES, N.J. and OREM, Utah, Jan. 30, 2024 -- (Healthcare Sales & Marketing Network) -- BD (Becton... Diagnostics, Oncology BD , Techcyte, cervical cancer, Pap smear (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2024 Category: Pharmaceuticals Source Type: news

IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class
IceCure exhibits and provides hands-on demonstrations at SIO 2024 Annual Meeting in California, receiving enthusiastic response from interventional oncologists ICE3 trial data were central to the Breast Cryoablation Master Class taught by several ProSen... Devices, Oncology IceCure Medical, ProSense System, cryoablation, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2024 Category: Pharmaceuticals Source Type: news

Introducing Sechrist's Innovative eHEAL and 3300HM Hyperbaric Chamber
ANAHEIM, Calif., Jan. 29, 2024 -- (Healthcare Sales & Marketing Network) -- Sechrist Industries, a leader in hyperbaric technology, is proud to announce the launch of two groundbreaking products: eHEAL and the 3300HM Hyperbaric Chamber. These new offering... Devices, Product Launch Sechrist Industries, hyperbaric chamber, eHEAL (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2024 Category: Pharmaceuticals Source Type: news

Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife(R) System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
New System Will Play a Key Role in Delivering Radiation Treatments in One of the Largest Cancer Facilities in Washington State MADISON, Wis., Jan. 25, 2024 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today... Devices, Oncology Accuray, radiosurgery, CyberKnife S7, CyberKnife, SBRT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2024 Category: Pharmaceuticals Source Type: news

ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
WATERTOWN, Mass., Jan. 24, 2024 -- (Healthcare Sales & Marketing Network) -- ZWI Therapeutics, Inc. (ZWI), a biotechnology company focused on the development of protein therapeutics using proprietary new polymers, announces a Series A financing, the appoi... Biopharmaceuticals, Personnel, Venture Capital ZWI Therapeutics, polycarboxybetaine, gout, arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 24, 2024 Category: Pharmaceuticals Source Type: news

FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
MADRID, Jan. 23, 2024 -- (Healthcare Sales & Marketing Network) -- Amadix, a Spanish biotech company, announced today that PreveCol®, its colorectal cancer screening blood test, has received Breakthrough Device Designation from the U.S. Food and Drug ... Diagnostics, Oncology, FDA Amadix , PreveCol , colorectal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2024 Category: Pharmaceuticals Source Type: news